Journal of Psychosomatic Research最新文献

{"title":"Antenatal anxiety symptoms and its contributing factors: The case in urban areas of Ethiopia","authors":"Koku S. Tamirat ,&nbsp;Sara Shishehgar ,&nbsp;Abel F. Dadi","doi":"10.1016/j.jpsychores.2025.112379","DOIUrl":"10.1016/j.jpsychores.2025.112379","url":null,"abstract":"<div><h3>Background</h3><div>Mental health challenges, such as depression and anxiety, commonly affect pregnant women and can have adverse health consequences for both the mother and the fetus. Despite their significant impact, anxiety symptoms in pregnant women are often inadequately addressed. This study aims to determine the prevalence of anxiety symptoms during pregnancy and identify contributing factors, with the goal of informing effective interventions.</div></div><div><h3>Methods</h3><div>We conducted a community-based cross-sectional study. We used a cluster sampling technique to recruit 940 study participants from selected clusters (sub-cities) in Gondar, Ethiopia. We assessed Anxiety symptoms using a set of three questions (Q 3, 4, &amp; 5) from the Edinburgh Postnatal Depression Scale (EPDS-3 A). We fitted a binary logistic regression model and computed the Adjusted Odds Ratio (AOR) with its 95 % Confidence Interval (CI).</div></div><div><h3>Result</h3><div>111 (11.9 %) of pregnant women had anxiety symptoms (95 %CI: 9.91 to 14.15). Compared to women with no formal education, those with secondary schooling had twice the odds of antenatal anxiety (AOR 2.05; 95 % CI 1.08–3.88). Likewise, women who faced food access problems in the past three months had 4.60 times the odds of anxiety compared with those without food issues (95 % CI 2.34–9.05); women with unplanned pregnancies had 2.53 times the odds relative to those with planned pregnancies (95 % CI 1.56–4.10); and those in their third trimester had 1.75 times the odds compared to women in the first trimester (95 % CI 1.10–2.79).</div></div><div><h3>Conclusions</h3><div>This study offers insight into the factors that play a role in the development of antenatal anxiety symptoms. Healthcare professionals should be well-informed about these factors and implement universal psychosocial screening for all pregnant women—ensuring timely identification of those at risk and enabling interventions that enhance their mental well-being.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"197 ","pages":"Article 112379"},"PeriodicalIF":3.3,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145082208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Increased use of psychiatric medication following incident celiac autoimmunity","authors":"Quinn Goddard ,&nbsp;Gilaad G. Kaplan ,&nbsp;Stephanie Coward ,&nbsp;Tyler Williamson ,&nbsp;Scott Patten ,&nbsp;Marcia Bruce ,&nbsp;Jenny Godley ,&nbsp;Rita Henderson ,&nbsp;Tara A. Whitten ,&nbsp;Araba Chintoh ,&nbsp;James A. King","doi":"10.1016/j.jpsychores.2025.112377","DOIUrl":"10.1016/j.jpsychores.2025.112377","url":null,"abstract":"<div><h3>Background</h3><div>Celiac disease is associated with an increased risk of psychiatric disorders, yet little is known about formal treatment for such conditions among patients.</div></div><div><h3>Methods</h3><div>Using administrative healthcare data, we conducted a population-based cohort study of individuals newly positive for celiac autoimmunity (tTG) between 2015 and 2023 in Alberta, Canada. Individuals were linked to medication dispensations to assess use of antidepressants, anxiolytics, and antipsychotics. We calculated the proportion of days covered (PDC) by psychiatric medication as the number of days for which medication was prescribed. We conducted identical sub-analyses for individuals with anxiety and/or depression-related healthcare encounters prior to their positive tTG test.</div></div><div><h3>Results</h3><div>Among 14,323 newly tTG-positive individuals, a greater proportion dispensed antidepressants (22.5 % vs 27.6 %) and antipsychotics (4.6 % vs 6.0 %) post-tTG, while a lower proportion dispensed anxiolytics post-tTG (15.4 % vs 11.4 %), all <em>p</em> &lt; 0.001. We observed higher odds of being dispensed psychiatric medication post-tTG (OR = 1.22; 95 % CI = 1.14, 1.31). Median PDC also significantly increased post-tTG test for antidepressants (2.8 % vs 21.1 %) and antipsychotics (0.4 % vs 6.3 %), <em>p</em> &lt; 0.001. However, a decreased odds of medication dispensation (OR = 0.42; 95 % CI: 0.32, 0.56) and median PDC post-tTG (45.1 % vs. 10.1 %, <em>p</em> &lt; 0.001) were observed among those with a previous depression/anxiety-related healthcare encounter.</div></div><div><h3>Conclusion</h3><div>These findings highlight a need for increased screening for and/or monitoring of psychiatric comorbidities in the celiac population, and further investigation into what may be underpinning greater use of psychiatric medications after tTG positivity.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"198 ","pages":"Article 112377"},"PeriodicalIF":3.3,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145092728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lifestyle factors, metabolic syndrome and apolipoprotein E in monozygotic twins with, at risk of and without affective disorders, as predictors of onset or recurrence of affective episodes, a seven-years follow-up study","authors":"Maj Vinberg ,&nbsp;Jon Dyg Sperling ,&nbsp;Ruth Frikke-Schmidt ,&nbsp;Thomas Scheike ,&nbsp;Lars Vedel Kessing ,&nbsp;Kamilla Miskowiak","doi":"10.1016/j.jpsychores.2025.112378","DOIUrl":"10.1016/j.jpsychores.2025.112378","url":null,"abstract":"<div><h3>Introduction</h3><div>This study explores lifestyle factors, metabolic syndrome (MetS), apolipoprotein E genotype (APOE), and plasma concentrations of apoE as predictors for the onset and recurrence of affective disorders.</div></div><div><h3>Methods</h3><div>We examined these factors in a seven-year follow-up study of 201 monozygotic twins (MZ) with unipolar or bipolar disorder (affected), their unaffected co-twins (high-risk), and twins with no personal or familial risk of affective disorder (low-risk).</div></div><div><h3>Results</h3><div>Higher body mass index (hazard ratio (HR) = 1.29, 95 % CI 1.11–1.50) and higher apoE plasma concentrations (HR = 1.09, 95 % CI 1.02–1.17) were significant predictors of onset. The APOE genotypes ε22 (HR = 2.85, 95 % CI 1.52–5.36) and ε43 + ε44 (HR = 2.42, 95 % CI 1.42–4.11) were predictors of onset or recurrence in the total sample. The ε22 genotype increased the HR = 5.04(95 % CI 2.25–11.31) in the affected group, while ε43 + ε44 genotypes predicted onset in the high-risk group (HR = 7.42, 95 % CI 1.76–31.36). Smoking was a predictor of onset or recurrence of affective episodes in the overall sample (HR = 2.15, 95 % CI 1.24–3.74) and in the low-risk group (HR = 39.10, 95 % CI 2.75–555.33).</div></div><div><h3>Conclusions</h3><div>The established risk genotypes APOE ε43 and ε44 were linked to the onset and recurrence of affective disorders in both affected and high-risk twins. Body mass index and smoking also emerged as significant risk factors. Furthermore, the predictors investigated may demonstrate different trajectories depending on familial risk for affective disorders. Overall, these findings underscore the importance of incorporating both biomarkers of and lifestyle factors into the prevention and treatment of patients with affective disorders.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"197 ","pages":"Article 112378"},"PeriodicalIF":3.3,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145060559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The relationship between death anxiety and fear of recurrence and progression in chronic illness: A systematic review and meta-analysis","authors":"Rachel E. Menzies ,&nbsp;Tadgh Connery ,&nbsp;Daniel Macdonald ,&nbsp;Grazia D. Riotto","doi":"10.1016/j.jpsychores.2025.112373","DOIUrl":"10.1016/j.jpsychores.2025.112373","url":null,"abstract":"<div><h3>Objective</h3><div>Recent research has identified fear of recurrence and fear of progression (FORP) as common psychosocial issues among people with chronic illnesses. Similarly, growing studies have identified death anxiety as being a key transdiagnostic construct in mental health, particularly in relation to anxiety. However, the relationship between these constructs has received scarce attention. This systematic review and meta-analysis examined the relationship between FORP and death anxiety across chronic illnesses.</div></div><div><h3>Methods</h3><div>The current review was conducted in line with PRISMA guidelines. We screened 2620 papers for the current systematic review and meta-analysis. In total, 15 studies were included in the final review (<em>N</em>_total <em>=</em> 3506).</div></div><div><h3>Results</h3><div>A meta-analysis revealed a significant and large correlation (<em>r</em> = 0.592) between death anxiety and overall FORP. The type of illness emerged as a significant moderator of this effect, with significantly larger effect sizes found for samples affected by cancer (<em>r</em> = 0.640) compared with other illnesses (<em>r</em> = 0.495). The relationship with death anxiety was equally strong between studies which measured fear of progression versus fear of recurrence. Overall, the studies were generally of high quality with low risk of publication bias.</div></div><div><h3>Conclusions</h3><div>The current findings support the significant relationship between death anxiety and FORP across numerous illness types. The clinical implications include the need to consider death anxiety in the conceptualisation and management of FORP in chronic illness.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"198 ","pages":"Article 112373"},"PeriodicalIF":3.3,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility of using a clinical measure of depression severity to assess treatment impact on total cost of care","authors":"Daniel Maeng,&nbsp;Hochang B. Lee,&nbsp;George S. Nasra","doi":"10.1016/j.jpsychores.2025.112375","DOIUrl":"10.1016/j.jpsychores.2025.112375","url":null,"abstract":"<div><h3>Objective</h3><div>Patient Health Questionnaire 9-item (PHQ9) has become a commonly used clinical measure of depression severity. This study therefore seeks to determine whether reductions in PHQ9 scores (i.e., symptom severity improvement) correspond to cost of care savings from the payer's perspective.</div></div><div><h3>Methods</h3><div>The study team obtained health insurance claims data and the PHQ9 scores of same individuals among employees of a large academic employer in the United States covering a two-year period from October 2016 to September 2018, limiting the sample to those who had at least two PHQ9 scores in two separate calendar months during a 12-month period, had initial score of 10 or above, and maintained continuous insurance enrollment for the 12-month period. The study team divided the sample into 3 mutually exclusive groups: no improvement within the 12-month period (NI; PHQ9 score remained unchanged or worsened), partial improvement (PI; 1 %–49 % improvement), or clinically significant improvement (CSI; ≥50 % improvement). Regression-adjusted mean total cost of care calculated on a per-member-per-year basis were then compared across the groups.</div></div><div><h3>Results</h3><div>The results indicated that relative to NI, CSI had incurred 36 % lower total cost of care (<em>p</em> = 0.032). However, no statistically significant association was found between NI and PI.</div></div><div><h3>Conclusion</h3><div>Although causal interpretations are difficult, these findings suggested clinically meaningful improvements in PHQ9 score are associated with lower total cost of care and that it is potentially feasible to develop a pay-for-performance scheme that align financial incentives with clinical outcomes. However, several barriers currently exist that prevent implementation in real-world settings.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"197 ","pages":"Article 112375"},"PeriodicalIF":3.3,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145019546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Associations of socioeconomic status and health-related quality of life in patients with long COVID and patients with persistent physical symptoms: A comparison of two cohort studies at baseline","authors":"Helena Liira,&nbsp;Mikko Varonen,&nbsp;Mikko S. Venäläinen,&nbsp;Jari Arokoski,&nbsp;Kirsi Kvarnström,&nbsp;Aki Vuokko,&nbsp;Antti Malmivaara","doi":"10.1016/j.jpsychores.2025.112374","DOIUrl":"10.1016/j.jpsychores.2025.112374","url":null,"abstract":"<div><h3>Background and aim</h3><div>Emerging evidence suggest a significant association between Long COVID (LC) and other persistent physical symptoms (PPS) with lower socioeconomic status (SES). We investigated the relationship between SES and health-related quality of life (HRQOL), as measured by the 15D and the EUROHIS-QOL-8 instruments, among patients with LC and those experiencing other PPS-related conditions.</div></div><div><h3>Methods</h3><div>Factors related to clinical and socioeconomic aspects that affect HRQOL were evaluated using 15D, a validated 15-item self-reported questionnaire. Two parallel cohorts at Helsinki University Hospital were analyzed: the Helsinki LC cohort (<em>n</em> = 422; 2021–2023) and the Helsinki Sympa cohort (<em>n</em> = 599; 2020–2024), consisting of patients with PPS. Additionally, we performed an intersectional MAIHDA analysis of biopsychosocial predictors of quality of life.</div></div><div><h3>Results</h3><div>The cohorts were demographically similar, with 70.6 % and 66.4 % female participants and mean ages of 44.8 years (SD = 11.3) and 38.8 years (SD = 11.0) in the LC and Sympa cohorts, respectively. By EUROHIS-QOL-8, 34 % of LC and 41 % of Sympa respondents rated their overall QOL as very bad or bad (scale options 1–2 out of 5). Mean 15D scores were 0.76 (SD = 0.11) in the LC cohort and 0.74 (SD = 0.11) in the Sympa cohort (scale: 0–1). Working status, comorbidities, and tertiary education emerged as key determinants in the information-criteria–based model, highlighting the cumulative burden of overlapping social and clinical disadvantages. No significant multiplicative effects were found within our cohorts.</div></div><div><h3>Conclusions</h3><div>Patients in both cohorts reported reduced HRQOL, and the influence of socioeconomic factors on QOL were highly similar. Comorbidities, only basic school education, and being out of work were associated with the lowest HRQOL scores. The accumulation of socioeconomic disadvantage may function as a barrier to treatment, and healthcare professionals should recognize these challenges and ensure that patients receive adequate support.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"197 ","pages":"Article 112374"},"PeriodicalIF":3.3,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145049077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A text message intervention to promote physical activity in midlife: The MASTERY randomized pilot trial","authors":"Christopher M. Celano ,&nbsp;Lily H. Jacobson ,&nbsp;Emily H. Feig ,&nbsp;Rachel A. Millstein ,&nbsp;Wei-Jean Chung ,&nbsp;Christina N. Massey ,&nbsp;Brian C. Healy ,&nbsp;Isabella Henneman ,&nbsp;Monika Sadlonova ,&nbsp;Nikita B. Acharya ,&nbsp;Jeff C. Huffman","doi":"10.1016/j.jpsychores.2025.112372","DOIUrl":"10.1016/j.jpsychores.2025.112372","url":null,"abstract":"","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"197 ","pages":"Article 112372"},"PeriodicalIF":3.3,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145049075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rasch analysis of the hospital anxiety and depression scale in patients with chronic fatigue syndrome","authors":"Emerson J. Bartholomew ,&nbsp;Oleg N. Medvedev ,&nbsp;Keith J. Petrie ,&nbsp;Trudie Chalder","doi":"10.1016/j.jpsychores.2025.112370","DOIUrl":"10.1016/j.jpsychores.2025.112370","url":null,"abstract":"<div><h3>Background</h3><div>The Hospital Anxiety and Depression Scale (HADS) is widely utilized for assessing psychological distress in medical populations, yet its clinimetric properties in chronic fatigue conditions remain underexplored. Given the complex symptom presentation in chronic fatigue syndrome (CFS), rigorous clinimetric validation is essential for accurate clinical assessment.</div></div><div><h3>Objective</h3><div>This study aimed to evaluate the clinimetric properties of the HADS using Rasch methodology in patients with CFS, with particular emphasis on dimensionality, item functioning, and measurement precision.</div></div><div><h3>Methods</h3><div>Rasch analysis was conducted on HADS responses from 286 participants diagnosed with CFS. The Partial Credit Rasch model was applied to assess overall model fit, item performance, unidimensionality and differential item functioning.</div></div><div><h3>Results</h3><div>Initial analysis revealed suboptimal model fit, necessitating subtest modifications to address local response dependence. The subtest solution demonstrated acceptable fit to the Rasch model with evidence of strict unidimensionality, high reliability (PSI = 0.87), and no differential item functioning by demographic variables. Rasch-converted interval scores showed improved measurement precision compared to ordinal scoring. Interval scoring yielding a significantly higher mean (M = 22.55, SD = 3.78) compared to unconverted scoring (M = 20.30, SD = 6.87), <em>t</em>(275) = −19.54, <em>p</em> &lt; .001, indicating that ordinal scoring systematically underestimates the latent trait level. Interval scores showed a 45 % reduction in measurement error demonstrated by the substantial reduction in standard error.</div></div><div><h3>Conclusions</h3><div>The HADS demonstrated acceptable measurement properties in patients with CFS. The development of ordinal-to-interval conversion tables enhances the scale's precision, supporting its continued use in clinical and research contexts.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"197 ","pages":"Article 112370"},"PeriodicalIF":3.3,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145049076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Path analysis of medication adherence in schizophrenia patients based on the extended theory of planned behavior: A cross-sectional study","authors":"Xuping Li ,&nbsp;Shuiyuan Xiao ,&nbsp;Yajun Sun ,&nbsp;Ying Zheng ,&nbsp;Yibin Hao ,&nbsp;Gang Tian","doi":"10.1016/j.jpsychores.2025.112371","DOIUrl":"10.1016/j.jpsychores.2025.112371","url":null,"abstract":"<div><h3>Background</h3><div>Medication adherence is a significant challenge among community-dwelling patients with schizophrenia. Understanding the influencing factors through the lens of behavioral theory can provide valuable guidance for designing effective interventions to improve medication adherence.</div></div><div><h3>Objectives</h3><div>This study aimed to identify the factors associated with medication adherence and the underlying mechanisms, based on the extended Theory of Planned Behavior (TPB), among community-dwelling patients with schizophrenia in China.</div></div><div><h3>Methods</h3><div>Medication adherence was measured using the seven-day recall method. Medication attitudes were assessed using the Drug Attitude Inventory-10-Item Version, perceived behavioral control was measured with the Self-Efficacy for Appropriate Medication Use Scale, and subjective norms, intention, and supervision were evaluated using self-developed items. Path analysis was conducted to test the hypotheses based on the extended TPB.</div></div><div><h3>Results</h3><div>A total of 468 community-dwelling patients with schizophrenia were surveyed, and 81.20 % of them demonstrated adherent. Intention (standardized effect: 0.897) and supervision (standardized effect: 0.084) were directly associated with medication adherence. Attitude (standardized effect: 0.268, computed as 0.299 × 0.897), subjective norms (standardized effect: 0.283, computed as 0.316 × 0.897), and perceived behavioral control (standardized effect: 0.187, computed as 0.208 × 0.897) were indirectly associated with medication adherence through intention.</div></div><div><h3>Conclusion</h3><div>The extended TPB is a suitable model for predicting medication adherence among community-dwelling patients with schizophrenia in China. It provides a robust framework for designing interventions targeting attitude, subjective norms, perceived behavioral control, and supervision to enhance medication adherence.</div></div>","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"197 ","pages":"Article 112371"},"PeriodicalIF":3.3,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144932764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Smartphone screen time reduction improves mental health: A randomized controlled trial","authors":"Christoph Pieh ,&nbsp;Elke Humer ,&nbsp;Doris Mayerhofer ,&nbsp;Rachel Dale ,&nbsp;Andreas Höngl ,&nbsp;Julia Schwab ,&nbsp;Katja Haider","doi":"10.1016/j.jpsychores.2025.112271","DOIUrl":"10.1016/j.jpsychores.2025.112271","url":null,"abstract":"","PeriodicalId":50074,"journal":{"name":"Journal of Psychosomatic Research","volume":"196 ","pages":"Article 112271"},"PeriodicalIF":3.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145009539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}